View ValuationTilray Brands 将来の成長Future 基準チェック /16Tilray Brandsは、130%と10.6%でそれぞれ年率130%で利益と収益が成長すると予測される一方、EPSはgrowで112.7%年率。主要情報130.0%収益成長率112.68%EPS成長率Pharmaceuticals 収益成長48.1%収益成長率10.6%将来の株主資本利益率n/aアナリストカバレッジGood最終更新日16 Apr 2026今後の成長に関する最新情報No longer forecast to breakeven Jul 29Forecast to breakeven in 2028 Jun 01Tilray Brands, Inc. Revises Revenue Guidance for the Fiscal Year 2025Apr 09Tilray Brands, Inc. Reaffirms Net Revenues Guidance for the Year 2025Jan 11No longer forecast to breakeven Nov 18No longer forecast to breakeven Sep 11すべての更新を表示Recent updatesTilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $180 million.Apr 16+ 1 more updateTilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $180 million.Apr 15Now 21% overvalued Apr 08Tilray Brands Inc Launches PORTALApr 08Third quarter 2026 earnings released: US$0.24 loss per share (vs US$8.69 loss in 3Q 2025) Apr 04Shock Top Launches High Voltage BeerMar 31Tilray Brands Announces Partnership With Popsicle To Launch Popsicle Adult BeveragesMar 27Tilray Brands, Inc. to Report Q3, 2026 Results on Apr 01, 2026Mar 25Tilray Medical Announces Major Expansion of Medical Cannabis Portfolio in AustraliaMar 20New minor risk - Profitability Mar 10Now 21% undervalued after recent price drop Feb 27Tilray Brands, Inc. Announces Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across CanadaFeb 27Now 22% undervalued after recent price drop Jan 28Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis PortfolioJan 23New minor risk - Shareholder dilution Jan 13Second quarter 2026 earnings: Revenues exceed analysts expectations while EPS lags behind Jan 09Now 20% undervalued after recent price drop Jan 07Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Al Alcoholic Beers and Hemp-Derived THC BeveragesJan 07Tilray Brands, Inc. to Report Q2, 2026 Results on Jan 08, 2026Dec 22New minor risk - Profitability Dec 21Now 24% overvalued after recent price rise Dec 16Tilray Brands, Inc. Announces the Launch of Amped Live Resin Liquid Diamond 1g 510 CartridgesDec 11Tilray Brands, Inc. Releases the Ultimate 2025 Holiday Drink Gift GuideDec 04Tilray Brands, Inc. Unveils Good Supply Vapes in Quebec Following the Recent Introduction of Vape Products in QuebecNov 24Now 22% undervalued after recent price drop Nov 20Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across CanadaNov 06Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard WorkOct 23First quarter 2026 earnings released: EPS: US$0 (vs US$0.045 loss in 1Q 2025) Oct 09Now 53% overvalued after recent price rise Sep 29Tilray Brands, Inc. to Report Q1, 2026 Results on Oct 09, 2025Sep 25Tilray Beverages Unveils New Fall Seasonal Craft Brews with Oktoberfest-Inspired LineupSep 23Tilray Brands, Inc., Annual General Meeting, Nov 18, 2025Sep 17Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis StrainsAug 28Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10Mg Drinks from Fizzy Jane's and Happy Flower BrandsAug 12President recently bought CA$138k worth of stock Jul 31New major risk - Shareholder dilution Jul 30Third quarter 2025 earnings released: US$0.87 loss per share (vs US$0.12 loss in 3Q 2024) Jul 29No longer forecast to breakeven Jul 29Tilray Brands, Inc. Announces Impairment of Intangible Assets and Goodwill for the Fourth Quarter Ended May 31, 2025Jul 29Tilray Brands, Inc. to Report Q4, 2025 Results on Jul 28, 2025Jul 09New minor risk - Share price stability Jul 02Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of Thc and Cbd FormulationsJun 26Tilray Brands, Inc. Announces 2025 Summer Cannabis Collection Offering by Its Wholly-Owned Licensed Cannabis Propose by its Wholly-Owned Cannabis Proprietary Cannabis Proprietary, and High Park Holdings LtdJun 24Tilray Brands, Inc.(TSX:TLRY) dropped from S&P/TSX Completion IndexJun 23+ 2 more updatesTilray Brands' Stockholders Approve Reverse Stock Split to Ensure Compliance with the Nasdaq Global Select Market's Continued Listing RequirementsJun 18Forecast to breakeven in 2028 Jun 01New minor risk - Profitability Apr 30New major risk - Shareholder dilution Apr 27Tilray Beverages Launches Cruisies, a New Line of Ready-To-Drink CocktailsApr 18Tilray Brands, Inc. Revises Revenue Guidance for the Fiscal Year 2025Apr 09Third quarter 2025 earnings: EPS and revenues miss analyst expectations Apr 08Tilray Brands, Inc. to Report Q3, 2025 Results on Apr 08, 2025Mar 28Tilray Brands Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price RequirementMar 26Tilray Brands, Inc. Introduces New Monsters Resin Vapes: Full Spectrum HighsFeb 20Tilray Medical Expands Medical Cannabis Portfolio in GermanyFeb 12Tilray Brands, Inc. Announces Successful Settlement of Aphria Canadian Class Action and Related Individual ActionsFeb 09Tilray Brands, Inc. Reaffirms Net Revenues Guidance for the Year 2025Jan 11Second quarter 2025 earnings: EPS and revenues miss analyst expectations Jan 10Now 29% undervalued after recent price drop Jan 10Tilray Brands, Inc. Explores the Latest Cannabis Beverages from Solei, Mollo, and XMGDec 31Tilray Brands, Inc. to Report Q2, 2025 Results on Jan 09, 2025Dec 19Redecan Cannabis, Brand Under Tilray Brands, Inc, Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-Roll Line for the HolidaysDec 18Tilray Brands, Inc. Appoints Steven M. Cohen as Class III Board MemberDec 15Tilray Brands, Inc. Launches New Product LineupDec 13Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC BeveragesDec 12New minor risk - Profitability Nov 18No longer forecast to breakeven Nov 18Tilray Brands, Inc. Announces Fall Craft Beer LineupOct 16First quarter 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Oct 10Tilray Brands Launches Charlotte's Web CBD Gummies in CanadaOct 07Tilray Brands, Inc. to Report Q1, 2025 Results on Oct 10, 2024Oct 01Tilray Brands, Inc., Annual General Meeting, Nov 21, 2024Sep 19No longer forecast to breakeven Sep 11New minor risk - Shareholder dilution Sep 08Tilray Brands, Inc. (NasdaqGS:TLRY) completed the acquisition of Terrapin Beer Co and Atwater Brewing Co. and Hop Valley Brewing Co and Revolver Brewing, LLC from Molson Coors Beverage Company (NYSE:TAP).Sep 04Entrepreneurial Equity Partners, L.P. acquired Truss Beverage Co. from Tilray Brands, Inc. (NasdaqGS:TLRY).Aug 18Tilray Brands, Inc. Announces the Expansion of its Solei Cannabis Product LineupAug 15 Jul 31Full year 2024 earnings: EPS misses analyst expectations Jul 30Tilray Brands, Inc. to Report Q4, 2024 Results on Jul 29, 2024Jul 16Get Ready to Elevate Your Cannabis Experience with Good Supply's Latest Signature Vape InnovationsJul 10Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic BrewsJun 27Tilray Brands, Inc. Announces the Launch of 'Purple Churro,' by Redecan CannabisJun 08Insufficient new directors Jun 02Tilray Brands, Inc. Announces Good Supply Launches 'Twisted' All-In-One VapeMay 31Forecast to breakeven in 2027 May 31Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’May 24Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $250 million.May 19Tilray Brands, Inc Launches XMG Zero, a New ‘Better for You’ Cannabis BeverageMay 03Tilray Brands, Inc.'s Subsidiary Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American HefeweizenMay 02Tilray Brands, Inc. Introduces New Signature 'Bud Squad' ProductsApr 24No longer forecast to breakeven Apr 10Third quarter 2024 earnings: EPS and revenues miss analyst expectations Apr 09Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis UseApr 03Tilray Brands, Inc. to Report Q3, 2024 Results on Apr 09, 2024Mar 29業績と収益の成長予測TSX:TLRY - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数5/31/20281,170-18124265/31/20271,101-39-152395/31/2026884-68-30-992/28/2026858-1,345-74-45N/A11/30/2025837-2,107-68-28N/A8/31/2025831-2,148-96-61N/A5/31/2025821-2,187-128-95N/A2/28/2025827-946-87-51N/A11/30/2024829-249-92-61N/A8/31/2024812-213-82-50N/A5/31/2024789-245-60-31N/A2/29/2024743-352-50-18N/A11/30/2023700-1,430-45-21N/A8/31/2023651-1,4581638N/A5/31/2023627-1,453-138N/A2/28/2023596-1,792-70-56N/A11/30/2022603-578-102-84N/A8/31/2022614-501-151-130N/A5/31/2022628-477-211-177N/A2/28/202261742-182-148N/A11/30/2021589-275-134-101N/A8/31/2021564-375-123-82N/A5/31/2021513-367-84-45N/A2/28/2021468-521-109-58N/A11/30/2020462-243-182-105N/A8/31/2020426-149-221-138N/A5/31/2020405-103-199-101N/A2/29/202038722-215-104N/A11/30/2019338-63N/A-78N/A8/31/2019263-16N/A-49N/A5/31/2019179-25N/A-42N/A2/28/201992-28N/A-33N/A11/30/20184363N/A-17N/A8/31/20183427N/A-12N/A5/31/20182823N/A-4N/A2/28/20182425N/A1N/A11/30/20172018N/A3N/A8/31/20171815N/A0N/A5/31/2017153N/A4N/A2/28/2017136N/A4N/A11/30/2016112N/A2N/A8/31/201691N/A1N/A5/31/201660N/A-1N/A2/29/20165-1N/A-2N/A11/30/20153-3N/A-3N/A8/31/20151-4N/A-3N/A5/31/20150-5N/A-4N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: TLRY今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: TLRY今後 3 年間、利益が出ない状態が続くと予測されています。高成長収益: TLRY今後 3 年間、利益が出ない状態が続くと予測されています。収益対市場: TLRYの収益 ( 10.6% ) Canadian市場 ( 5% ) よりも速いペースで成長すると予測されています。高い収益成長: TLRYの収益 ( 10.6% ) 20%よりも低い成長が予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: TLRYの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/03 03:38終値2026/05/01 00:00収益2026/02/28年間収益2025/05/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Tilray Brands, Inc. 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。27 アナリスト機関Aaron GreyAlliance Global PartnersFrederico Yokota Choucair GomesATB CormarkJesse PytlakATB Cormark Historical (Cormark Securities)24 その他のアナリストを表示
Tilray Brands, Inc. has filed a Follow-on Equity Offering in the amount of $180 million.Apr 16+ 1 more update
Tilray Brands, Inc. Announces Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across CanadaFeb 27
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis PortfolioJan 23
Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Al Alcoholic Beers and Hemp-Derived THC BeveragesJan 07
Tilray Brands, Inc. Unveils Good Supply Vapes in Quebec Following the Recent Introduction of Vape Products in QuebecNov 24
Tilray Medical Sets the Standard for Compassionate Pricing, Broadening Access to Medical Cannabis for Patients, Seniors, First Responders, and Veterans Through Expanded Pricing Programs Across CanadaNov 06
Redhook Brewing Launches Redhook 81, Celebrating Pacific Northwest Roots and the Spirit of Hard WorkOct 23
Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis StrainsAug 28
Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10Mg Drinks from Fizzy Jane's and Happy Flower BrandsAug 12
Tilray Brands, Inc. Announces Impairment of Intangible Assets and Goodwill for the Fourth Quarter Ended May 31, 2025Jul 29
Tilray Medical Publishes Pioneering Research on the Pharmacokinetics of Thc and Cbd FormulationsJun 26
Tilray Brands, Inc. Announces 2025 Summer Cannabis Collection Offering by Its Wholly-Owned Licensed Cannabis Propose by its Wholly-Owned Cannabis Proprietary Cannabis Proprietary, and High Park Holdings LtdJun 24
Tilray Brands' Stockholders Approve Reverse Stock Split to Ensure Compliance with the Nasdaq Global Select Market's Continued Listing RequirementsJun 18
Tilray Brands Receives Non-Compliance Letter from Nasdaq Regarding Minimum Bid Price RequirementMar 26
Tilray Brands, Inc. Announces Successful Settlement of Aphria Canadian Class Action and Related Individual ActionsFeb 09
Redecan Cannabis, Brand Under Tilray Brands, Inc, Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-Roll Line for the HolidaysDec 18
Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC BeveragesDec 12
Tilray Brands, Inc. (NasdaqGS:TLRY) completed the acquisition of Terrapin Beer Co and Atwater Brewing Co. and Hop Valley Brewing Co and Revolver Brewing, LLC from Molson Coors Beverage Company (NYSE:TAP).Sep 04
Entrepreneurial Equity Partners, L.P. acquired Truss Beverage Co. from Tilray Brands, Inc. (NasdaqGS:TLRY).Aug 18
Get Ready to Elevate Your Cannabis Experience with Good Supply's Latest Signature Vape InnovationsJul 10
Tilray Brands, Inc. Announces Runner's High Brewing Company - Its New Brand of Premium Non-Alcoholic BrewsJun 27
Tilray Brands, Inc.'s Subsidiary Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American HefeweizenMay 02
Tilray Medical Announces New Scientific Publication on Age-Related Patterns of Medical Cannabis UseApr 03